You are here: Home » Pharmacy Practice

Pharmacy Practice

Remdesivir, the pharmacy budget buster

By Jerry Fahrni on May 1, 2021

I saw the discussion below in one of the pharmacy forums. Fact check true on this one. Gilead would have everyone believe that remdesivir is a magic bullet for COVID-19 infection. Not true. Helpful? Useful tool? Maybe. Remdesivir, while potentially beneficial, has limitations. For one, it should only be used on hospitalized patients that have […]

Posted in | Tagged , , , , , , |

Pharmacy – Relying on 503Bs is a mistake

By Jerry Fahrni on April 3, 2021

What’s a 503B FDA outsourcing facility? Well, just sit right back and you’ll hear a tale, a tale of a fateful trip, that started from this tropic port, aboard this tiny ship…. just kidding, it’s what popped into my head when I started writing, but we really should define what a 503B is. The 503B […]

Posted in | Tagged , , , , |

Pharmacy – Lessons from a pandemic

By Jerry Fahrni on March 24, 2021

Quite some time ago I took to writing things down in a paper rather than digital notebook. This morning, as people will do when they are bored, I picked up one of those notebooks and began thumbing through the pages. Not too far in, I came across some notes dated Sunday, April 5, 2020 that […]

Posted in | Tagged , , |

The impact of COVID-19 on Pharmacy Personal Protective Equipment (PPE)

By Jerry Fahrni on March 22, 2020

COVID-19 has taught us many things, among them that our healthcare supply chain is poorly designed and flimsy. Just a few weeks into the pandemic and our supply chain for Personal Protective Equipment (PPE) has been completely disrupted. PPE is now in short supply, and I suspect that we will run out of PPE in […]

Posted in | Tagged , , , , , , | | Leave a response

Pharmacy Integration is Starting to Make Sense

By Jerry Fahrni on March 15, 2020

I’ve been writing about the need for pharmacy integration for years. Most of it negative, and deservedly so because it’s been lousy. With that said, things appear to have changed in recent years. Integration, it seems, has slowly become a thing. Maybe because I’ve been out of general pharmacy practice for so long that it […]

Posted in , , , | | 1 Response

Today’s sterile compounding climate is a lesson on availability cascades

By Jerry Fahrni on July 13, 2019

I’ve been slowly reading ‘Thinking, Fast and Slow’, a best-selling book by Daniel Kahneman, a Nobel Prize winning psychologist and economist known for his work on the psychology of judgment and decision-making.  The book summarizes behavioral science research conducted by Kahneman. The recurring theme of the book is what the author defines as two modes […]

Posted in , | Tagged , , , | | Leave a response

Chapter 8: First things first

By Jerry Fahrni on March 30, 2019

Several years ago, shortly after I was let go from Talyst, I found myself with some free time on my hands. I started writing a book. The book was titled ‘Making the right choice: Helping pharmacies make smart decisions about automation and technology’. Like many books I’ve started, it remains unfinished. I don’t think I’ve […]

Posted in , | Tagged , , | | Leave a response

Disruptive technologies in pharmacy, reality or myth?

By Jerry Fahrni on December 23, 2018

There was an interesting thread in one of the ASHP practice forums recently. Someone asked whether or not pharmacists were “ready for the future that the opportunities these disruptive technologies offer”. This in reference to technologies that they saw in the exhibit hall at ASHP Midyear. The simple answer is no. Pharmacists are barely ready […]

Posted in , , | Tagged , |

ASHP Midyear 2018: Initial Thoughts

By Jerry Fahrni on December 16, 2018

I recently returned from the 2018 ASHP Midyear Clinical Meeting, i.e. “Midyear” in Anaheim, CA. This year was a bit different for me as it was the first time in many years that I attended the meeting as a regular pharmacist, i.e. not tied to a pharmacy automation company as an employee or as a […]

Posted in | Tagged , , , , , | | Leave a response

Building a sterile compounding space in California – Regulatory Hurdles

By Jerry Fahrni on August 12, 2018

For almost a year, I’ve been working as a ‘Pharmacy Project Manager’ on a large healthcare system project to bring all their pharmacy sterile compounding spaces — a.k.a. Cleanrooms, SCA’s, C-SCA’s, etc. — into compliance with USP General Chapters <797> and <800>. Some areas have been remodeled while others have simply been scrapped in favor […]

Posted in | Tagged , , , , | | Leave a response